POLYMORPHISM OF THE CYP2C19 ISOENZYME AS A RISK FACTOR FOR GASTROPATHIES INDUCED BY THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH PAIN SYNDROME
Keywords:
NSAID, PPIs, Cytochrome P450, gastropathy, gastroduodenal damageDownloads
Published
2022-10-03
How to Cite
Lola T. Daminova, Abror Sh. Kasimov, & Zafar B. Abdashimov. (2022). POLYMORPHISM OF THE CYP2C19 ISOENZYME AS A RISK FACTOR FOR GASTROPATHIES INDUCED BY THE USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN PATIENTS WITH PAIN SYNDROME. Central Asian Journal of Medicine, (3), 159-166. Retrieved from https://mail.journals.tma.uz/index.php/cajm/article/view/515
Issue
Section
Articles